Certolizumab Pegol (Ucb, Inc)


Indications and Reactions:

Role Indications Reactions
Primary
Crohn's Disease 86.9%
Rheumatoid Arthritis 10.1%
Hepatic Pain 2.0%
Colitis Ulcerative 1.0%
Drug Ineffective 10.3%
Fatigue 8.7%
Frequent Bowel Movements 8.7%
Crohn's Disease 7.1%
Abdominal Pain 6.3%
Injection Site Pain 6.3%
Pain 5.6%
Pyrexia 5.6%
Arthralgia 4.8%
Diarrhoea 4.8%
Malaise 4.0%
Pregnancy 4.0%
Constipation 3.2%
H1n1 Influenza 3.2%
Influenza 3.2%
Nausea 3.2%
Oedema Peripheral 3.2%
Urinary Tract Infection 3.2%
Drug Effect Decreased 2.4%
Insomnia 2.4%

Drug Data